Posts Tagged ‘pharmaceutical’
« Older Entries | Newer Entries »
National Pharmacare – Time to Get on With It
Friday, November 3rd, 2023
The federal government can act as a catalyst by making a credible and responsible financial commitment that opens the door to joint work with provinces and territories to improve public plan coverage. The PEI agreement is a good model and federal legislation can help to create a positive foundation for collaboration. The political window to move things forward is open, but not for long.
Tags: featured, Health, ideology, jurisdiction, mental Health, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
The Liberals have a chance to make headway on pharmacare. They should seize the opportunity
Thursday, November 2nd, 2023
Hoskins had recommended that a universal program begin with essential medicines, which would initially cost the government $3.5 billion to $4.5 billion. The NDP insists on a single-payer universal system but acknowledges it can’t be done in one fell swoop. It has demanded that timelines for progress be enshrined in legislation. If all this leads to a “foundational” piece of legislation and a firm road map going forward, that will be welcome and significant progress in a time of economic uncertainty.
Tags: budget, disabilities, economy, featured, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Ontario plans to expand midwives’ prescribing power
Tuesday, October 31st, 2023
Ontario is planning to expand the list of drugs that midwives can prescribe and administer, including allowing them to prescribe birth control… A spokesperson for Health Minister Sylvia Jones said the ministry is reviewing further scope-of-practice changes and is rolling them out based on advice from health-care partners.
Tags: Health, pharmaceutical, women
Posted in Health Policy Context | No Comments »
Budget officer estimates cost and savings of single-payer pharmacare
Thursday, October 19th, 2023
The PBO says, “Upon the implementation of a single-payer universal drug plan… we estimate the incremental cost to the public sector (that is, federal and provincial governments) combined to be $11.2 billion in 2024-25, increasing to $14.4 billion in 2027.” In terms of the economy as a whole, the PBO estimates cost savings on drug expenditures of $1.4 billion in 2024-25, rising to $2.2 billion in 2027-28.
Tags: budget, economy, Health, jurisdiction, mental Health, participation, pharmaceutical
Posted in Health Debates | No Comments »
Politicians come and go, but the clock is now ticking on long-promised pharmacare
Thursday, October 12th, 2023
Federal funding of essential medicines will, of course, cost the federal government, since it would foot the bill for all of those essential medicines instead of the provinces paying much of the costs. But the $7.6 billion price tag is a bargain. All told, a program of this kind could save provinces, employers and families $12 billion in reduced prescription drug costs. The $4 billion in direct savings for provinces alone is enough to entice even the most recalcitrant of provincial governments.
Tags: featured, Health, ideology, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
How we can actually achieve national pharmacare – Hill Times Op-Ed
Sunday, September 17th, 2023
A national public single payer drug plan… implementation requires massive administrative changes and costs… there are two other models that would work. Social insurance has been used in Canada and in many countries that have broader, higher quality universal health systems, most at lower per capita costs. A second, more targeted approach is a portable health benefit plan which uses a similar mixed funding model to help workers with no health insurance.
Tags: Health, pharmaceutical
Posted in Health Policy Context | No Comments »
Liberals’ fortunes hinge on Holland’s pharmacare: coalition director
Thursday, September 14th, 2023
“Only a single-payer Pharmacare system will achieve the savings, efficiencies and fairness that is the hallmark of Canadian Medicare. Anything less will be unacceptable to Canadians and the NDP,” NDP health critic Don Davies declared in June, backing the view of Dr. Eric Hoskins. Public health care experts and organizations like the Canadian Health Coalition, and every commission that’s looked at the problem, agree.
Tags: Health, ideology, jurisdiction, pharmaceutical, standard of living
Posted in Governance Debates | No Comments »
CHC chair calls for progress on pharmacare implementation
Thursday, August 17th, 2023
We are calling on the new minister to implement public universal pharmacare. Don’t be fooled by the blandishments and manipulations of the pharmaceutical industry, which obviously opposes public universal pharmacare… We also hope he won’t be too impressed by caucus colleagues who are trying to placate the ferocious and well-financed pharma lobby on the Hill.
Tags: Health, ideology, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Health Coalition wants $3.5 Billion in Budget for Pharmacare
Wednesday, August 16th, 2023
If accepted, the government would fulfill a key recommendation of the 2019 Final Report of the Advisory Council on the Implementation of National Pharmacare, led by Dr. Eric Hoskins, which estimated that it will cost an additional $3.5 billion to launch national pharmacare starting with universal coverage for essential medicines. Here are the coalition’s four recommendations…
Tags: featured, Health, jurisdiction, mental Health, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Canada has in fact achieved universal drug insurance coverage
Saturday, August 12th, 2023
People in the lowest income deciles are eligible for public safety-net coverage at zero or very low costs. People in the highest income deciles are covered when prescription drug costs exceed 3 per cent to 7 per cent of family income, depending on the jurisdiction. Typically, private drug plans use deductibles and copayments and end up insuring about 80 per cent of prescription costs.
Tags: economy, Health, ideology, participation, pharmaceutical, privatization, standard of living
Posted in Health Debates | No Comments »
Recent Comments